The single-dose vaccine returns after six weeks of absence
Em meio à longa jornada de imunização contra a COVID-19, Minas Gerais aguardava, na segunda-feira de setembro de 2021, a chegada de mais de 890 mil doses de vacinas — a quinquagésima terceira remessa desde o início da campanha. O retorno da vacina Janssen, ausente desde o início de agosto, conferia ao momento um significado particular: a dose única representa um caminho mais acessível para aqueles que, por circunstância ou hesitação, não retornariam a um segundo compromisso. Com dois terços da população já vacinados com ao menos uma dose, o estado avançava, ainda que perguntas sobre a distribuição permanecessem sem resposta.
- Após seis semanas de ausência, a vacina Janssen retorna a Minas Gerais — um sinal de que as cadeias de abastecimento, antes fragilizadas, começam a se estabilizar.
- A remessa de 890.110 doses chega em etapas: AstraZeneca pela manhã no aeroporto de Confins, Pfizer por via terrestre no fim da tarde — uma logística que exige coordenação precisa.
- Com 67% da população tendo recebido ao menos uma dose e apenas 34% com o esquema completo, a pressão para acelerar a imunização plena permanece intensa.
- O governo estadual ainda não definiu quais grupos populacionais receberão as doses nem como serão distribuídas aos municípios, deixando gestores locais e cidadãos em compasso de espera.
Na segunda-feira, 20 de setembro de 2021, Minas Gerais aguardava a chegada de 890.110 doses de vacinas contra a COVID-19 — a quinquagésima terceira remessa desde o início da campanha de imunização no estado. O lote reunia três imunizantes: AstraZeneca, Pfizer e, de forma especialmente simbólica, a Janssen, que não chegava ao estado desde o início de agosto.
A entrega seria escalonada ao longo do dia. Duas remessas de AstraZeneca, totalizando 312.500 doses, pousariam no Aeroporto Internacional de Confins pela manhã. À tarde, 576.810 doses da Pfizer chegariam por via terrestre. Os 800 frascos da Janssen representavam uma fração menor do total, mas carregavam peso próprio: por exigirem apenas uma aplicação, são especialmente úteis para alcançar pessoas que dificilmente retornariam para uma segunda dose.
O avanço da vacinação em Minas era visível nos números: cerca de dois terços da população já havia recebido ao menos uma dose, e pouco mais de um terço havia completado o esquema vacinal. O Ministério da Saúde havia enviado ao estado aproximadamente 27,1 milhões de doses até aquele momento.
Ainda assim, incertezas persistiam. O governo estadual não havia anunciado quais grupos populacionais seriam contemplados com as novas doses nem como o lote seria distribuído entre os municípios mineiros — deixando autoridades locais e a população à espera de orientações que ainda estavam por vir.
Minas Gerais was expecting a significant shipment of coronavirus vaccines to arrive on Monday, September 20th—890,110 doses in total, marking the fifty-third delivery the state had received since the immunization campaign began. The arrival would be notable for one reason in particular: the return of Janssen vaccines, the single-dose formulation that had been absent from the state's supply since early August.
The shipment would arrive in stages throughout the day. Two batches of AstraZeneca vaccine—312,500 doses combined—were scheduled to land at Confins International Airport in the morning, the first touching down at 7:20 a.m. and the second at 9:20 a.m. Later in the afternoon, at 5:30 p.m., a terrestrial delivery would bring 576,810 doses of Pfizer vaccine. The Janssen doses, numbering 800, represented a smaller portion of the overall haul but carried symbolic weight: they required only a single injection, making them valuable for reaching people who might otherwise delay or avoid vaccination.
By mid-September, the vaccination effort in Minas Gerais had achieved measurable progress. According to the state's vaccine tracking system, roughly two-thirds of the population had received at least one dose. Just over one-third had completed their vaccination—either having received both shots of a two-dose regimen or the single dose of Janssen. The federal Ministry of Health had shipped approximately 27.1 million doses to the state up to that point, a substantial commitment to the immunization campaign.
Yet significant questions remained unanswered. The state government had not yet announced which population groups would receive the incoming doses or how the vaccines would be distributed across Minas's municipalities. This lack of clarity meant that local health officials and the public would have to wait for further guidance before understanding how the new supply would reshape vaccination schedules in their communities.
The arrival of the Janssen vaccine was particularly significant given its absence over the previous six weeks. Single-dose vaccines had proven valuable in vaccination campaigns worldwide, offering a faster path to protection for people who could not or would not return for a second appointment. Its return to Minas suggested that supply chains, disrupted earlier in the year, were beginning to stabilize—though the relatively small number of Janssen doses arriving indicated that two-dose vaccines would continue to dominate the state's immunization strategy.
La Conversación del Hearth Otra perspectiva de la historia
Why does the return of Janssen matter so much if it's only 800 doses out of nearly 900,000?
Because it signals something about supply. Janssen disappeared for six weeks. When a vaccine vanishes and then reappears, it tells you something shifted upstream—maybe production ramped up, maybe priorities changed. For people who can only get one shot, it matters enormously.
But two-thirds of the state already has one dose. Aren't they mostly waiting for their second?
Yes, but not everyone. There are always people who haven't started, people who are hesitant, people who missed their window. A single-dose option removes friction. It's the difference between "come back in four weeks" and "you're done."
The state hasn't said who gets what yet. How does that work operationally?
It's a gap. Local health departments are probably waiting on a call or an email that tells them their allocation. Until then, they can't plan their clinics. It's the kind of thing that looks like a small administrative detail but actually slows everything down.
Is 67% vaccinated considered good progress by September 2021?
It depends on context. By global standards, it was solid. But Brazil was still in the thick of the pandemic. Every percentage point mattered. And the gap between first dose and full vaccination—67% to 34%—shows people were still in the pipeline, still vulnerable.
What does the fifty-third shipment tell you?
Consistency. The state was receiving vaccines regularly, week after week. No dramatic surges, no long gaps. It was the grinding work of a campaign that had found its rhythm, even if the rhythm wasn't fast enough to satisfy anyone.